Results 151 to 160 of about 43,232 (314)

Une modification de la protéine non-structurale NS1 d'un virus influenza aviaire accroit sa virulence et son pouvoir replicatif

, 2015
Sascha Trapp, Denis Soubieux, Hélène Marty, Evelyne Esnault, Adrien Lion, Emmanuel Kut, Pascale Quéré, Thibaut Larcher, Nadia Naffakh, Daniel Marc   +9 more
openalex   +1 more source

Vacuna contra el virus de la influenza y exacerbaciones de EPOC, un estudio transversal

Hernando Torres‐Zevallos, Eneyda Giuvanela Llerena-Zegarra, José Luis Cabrera, Rolando Estrella, Alejandro Peña, Lorena Mata, Wilmer Cristobal Guzman‐Vilca, William J. Garcia, L Botero, S. Gutiérrez, Alfredo Guerrero-Benavides   +10 more
openalex   +2 more sources

Estimation of General Practitioner Visits, Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus and Influenza Virus, and Costs Associated With Hospitalizations, in Older Adults in France From 2010 to 2020. [PDF]

Open Forum Infect Dis
Nuttens C, Barbet V, Bignon-Favary C, Lambourg E, Fiévez S, Blanc E, Vacheret M, Liliu H, Vanhems P, Casalegno JS, Watier L, Loubet P, Liang C, Begier E, Lemaitre M.   +14 more
europepmc   +1 more source

Host‐Directed Antiviral Activity of SB2960 Through Selective Induction and Remodeling of Stress Granules

Advanced Science, EarlyView.
Amid the ongoing threat of emerging viral pathogens, host‐directed antivirals offer a strategy to overcome viral mutation and drug resistance. SB2960, a small‐molecule inducer of stress granules (SGs), exhibits potent broad‐spectrum antiviral activity with minimal cytotoxicity.
Wan Gi Byun, Sumin Son, JinAh Lee, Minha Lee, Meehyun Ko, Songrui Zhao, Ju Hee Kim, Kannan Vaithegi, Ji Hoon Kwon, Jung Ho Lee, Sangeun Jeon, Dawon Yi, Peng Zou, Seungtaek Kim, Seung Bum Park   +14 more
wiley   +1 more source

Epidemiología molecular de los virus influenza humanos circulantes en la Argentina en el período 1995-2002

, 2003
Andrea Pontoriero
openalex   +1 more source

Coévolution de la balance fonctionnelle de l’hémagglutinine et la neuraminidase chez les virus influenza de type A

, 2023
Grégory Quéromès
openalex   +1 more source

Interim vaccine effectiveness against influenza virus among outpatients, France, October 2025 to January 2026. [PDF]

Euro Surveill
De Clercq A, Blanquart F, Vieillefond V, Visseaux B, Jacques A, Haim-Boukobza S, Wehrle V, Deleglise G, Duret T, Bernard-Stoecklin S, Perez-Bercoff D, Oblette A, Lina B, Rameix-Welti MA, Josset L, Enouf V, Bal A, RELAB study group.   +17 more
europepmc   +1 more source

⁠Engineering Adaptive Immunity in 3D: A Patient‐Specific Lymphoid Model Using Stromal Networks and Peripheral Blood Mononuclear Cells

Advanced Science, EarlyView.
This study presents a 3D lymphoid tissue model engineered from adipose‐derived stem cells differentiated into fibroblastic reticular cell–like networks and co‐cultured with immune cells. The engineered system successfully generates antigen‐specific antibodies and cytokine responses, providing a platform for studying adaptive immunity, vaccine efficacy,
Mei ElGindi, Shaza Karaman, Jeremy Teo
wiley   +1 more source

Niveles de protección contra la hemaglutinina del virus de influenza A/ Johannesburg/82/96(H1N1) en un hogar de ancianas

, 2010
Suset Oropesa, Barbara Hernández, Marlene Pérez, Graciela Herrera, Celia Tait, Consuelo Menéndez, Juana Toma, Mercedes Biset, Gladys Travieso, Ileana Borrego, B Proy Vega, Lizet Sánchez   +11 more
openalex   +1 more source

Autoantibodies neutralizing type I IFNs in a fatal case of H5N1 avian influenza. [PDF]

J Exp Med
Zhang Q, Conrad TS, Moncada-Velez M, Jiang K, Cupic A, Eaton J, Hutchinson K, Gervais A, Chen R, Puel A, Bastard P, Cobat A, Sokol T, Langlois RA, Miorin L, García-Sastre A, Vanchiere JA, Casanova JL.   +17 more
europepmc   +1 more source